fumarate hydratase Antibodies

Santa Cruz Biotechnology features a diverse variety of fumarate hydratase monoclonal antibodies for research applications. fumarate hydratase Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fumarate hydratase plays a vital role in the tricarboxylic acid (TCA) cycle, facilitating the conversion of fumarate to malate, which is essential for cellular respiration and energy production. Mutations in the fumarate hydratase gene are associated with hereditary leiomyomatosis and renal cell cancer, highlighting its significance in both metabolic processes and cancer biology. Understanding the function and regulation of fumarate hydratase continues to be a key focus in metabolic research. Recent studies have revealed new insights into how fumarate hydratase dysfunction impacts cellular metabolism and disease progression. Researchers worldwide are exploring the relationship between fumarate hydratase and various pathological conditions. Santa CruzBiotechnology monoclonal antibodies enable researchers to advance scientific understanding of metabolic diseases and cancer biology.